万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

10.3978/j.issn.1000-9604.2013.05.01

Pharmacological blockage of CYP2E1 and alcohol-mediated liver cancer: is the time ready?

引用
Chronic alcohol consumption is a major risk factor worldwide affecting significantly both mortality and years of life lost (YLL) (1).Ca.5% of the western world show risky alcohol consumption and in some countries such as China a regional yearly increase of alcohol consumption of over 400% has been observed recently (2,3).The liver is the major target organ of alcohol.According to the recently published ‘Global Burden of Disease Study 2010”,liver cirrhosis and liver cancer are ranked at position 12 and 16 in the global deaths statistics (1).Thus,in 2010,ca.1 million people died from liver cirrhosis with one third directly attributable to alcohol.This is a considerable number when comparing with coronary heart disease with 7 million deaths and the leading cause of mortality.In central Europe,liver cirrhosis even ranks at the fourth position in YLL.Hepatocellular cancer (HCC) is now the most common fatal complication of patients with alcoholic cirrhosis.

liver cirrhosis、coronary heart disease、liver cancer、risk factor

25

R5 ;R54

2013-09-09(万方平台首次上网日期,不代表论文的发表时间)

共3页

269-271

相关文献
评论
暂无封面信息
查看本期封面目录

中国癌症研究(英文版)

1000-9604

11-2591/R

25

2013,25(3)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn